Increased menin expression in sporadic pituitary adenomas

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Germline mutations in the multiple endocrine neoplasia type 1 (MEN1) gene cause MEN1 syndrome, with menin (the gene product) often downregulated or truncated in associated tumors.
• Exonic MEN1 mutations are rare in sporadic pituitary adenomas, suggesting menin may not be a primary driver in these tumors.
• Alternative mechanisms like intronic mutations or epigenetic changes could potentially downregulate menin in sporadic pituitary adenomas.

Purpose of the Study:

• To investigate the role of MEN1 gene mutations and menin protein expression in the development of sporadic pituitary adenomas.
• To screen for novel MEN1 mutations in sporadic pituitary tumors.
• To assess menin protein levels in these adenomas.

Main Methods:

• Screening of MEN1 coding and flanking intronic regions in 136 sporadic pituitary adenomas using temporal temperature gradient gel electrophoresis (TTGE).
• Sequencing of identified aberrant DNA bands to detect mutations.
• Immunoblotting analysis of menin expression in 11 tumor samples and non-neoplastic adenohypophysis.

Main Results:

• Five novel somatic MEN1 mutations were identified, including missense, deletion, and intronic mutations.
• No significant association was found between identified MEN1 mutations and sporadic pituitary adenomas.
• Menin protein was upregulated in all examined adenomas, contradicting the hypothesis of menin downregulation.

Conclusions:

• MEN1 gene mutations do not appear to play a significant role in the pathogenesis of sporadic pituitary adenomas.
• Menin downregulation is unlikely to be a key mechanism in the development of these tumors.
• The findings suggest alternative pathways are involved in sporadic pituitary adenoma formation.